Hypertension (High Blood Pressure) News and Research

RSS

Hypertension (or high blood pressure) is a condition where the pressure of the blood flowing through the arteries of the body is higher than it should be. Much like the pressure of the air in a tire, if the pressure of the blood is too high it can damage the arteries and organs of the body. Just like the tire, if the pressure suddenly becomes very high, catastrophic events can happen. Similarly, if the pressure remains somewhat elevated for a long enough period of time, premature wear and failure can occur.

Hypertension has its worst effects on the heart, kidneys, eyes, and brain. High blood pressure is a risk factor for heart attack, stroke, kidney failure, hemorrhages of the retina of the eye, and generalized atherosclerosis (hardening of the arteries all over the body).

New target for cancer cure identified

Researchers Dr. Marc Therrien at the Institute for Research in Immunology and Cancer (IRIC) of the Universit- de Montr-al, and Dr. Frank Sicheri, at the Samuel Lunenfeld Research Institute of Mount Sinai Hospital in Toronto, have discovered a new target that may be instrumental in the development of new, more effective cancer therapies.

3 Sep 2009

The Kyoto Heart study shows positive effect of valsartan on cardiovascular outcome

The KYOTO HEART Study, which took place in Japan between January 2004 and January 2009, shows that the addition of valsartan to conventional antihypertensive treatment to improve blood pressure control is associated with an improved cardiovascular outcome in Japanese hypertensive patients at high risk of CVD events.

2 Sep 2009

LifeVantage granted third patent for Protandim

LifeVantage Corporation, has been granted a third patent for its flagship product Protandim from the United States Patent and Trademark Office. Protandim has been clinically proven in earlier studies to slow the progressive rate of aging by reducing oxidative stress and this new patent further documents Protandim’s® effect on antioxidant enzymes in vivo, describing anti-inflammatory effects such as the lowering of C-reactive protein.

2 Sep 2009

Study reveals that valsartan prevents cardiovascular events in high-risk hypertensive Japanese patients

2 Sep 2009

Actelion launches new 20 mcg/mL Ventavis formulation

Actelion Pharmaceuticals US, Inc., today announced the first commercial sales of a new 20 microgram per milliliter (mcg/mL) formulation of Ventavis(R), for the treatment of New York Heart Association Class III and IV pulmonary arterial hypertension (PAH). This increased strength formulation delivers the same dose of Ventavis in half the volume, which is expected to reduce inhalation time and further support patient compliance.

2 Sep 2009

Irbesartan drug minimizes heart failure complications in patients with atrial fibrillation

In a major international trial, researchers from McMaster University in Canada, found that the hypertension drug irbesartan reduced the risk of heart failure complications and the combination of stroke, other embolic events and transient ischemic events, also known as ministrokes, in patients with atrial fibrillation.

2 Sep 2009

White paper stresses the need for healthy living and prevention to be included in healthcare reform

Healthy living and pharmacy Expert and Commentator Marc Isaacson, CEO of Village Green Apothecary, the leading integrative pharmacy in the United States, announced today the release of their white paper, which provides a statistical analysis that explains why healthy living and prevention should be included, if not the focus of Healthcare Reform.

2 Sep 2009

Scientists shed light on the relationship between hypertension and obesity

Some of the first information about how fat causes hypertension have been identified by researchers who say the findings should one day help identify which obese people - and maybe some thin ones too - are at risk for hypertension and which drugs would work best for them.

2 Sep 2009

Biotransformed blueberry juice can function as anti-obesity and anti-diabetic agent

Juice extracted from North American lowbush blueberries, biotransformed with bacteria from the skin of the fruit, holds great promise as an anti-obesity and anti-diabetic agent. The study, published in the International Journal of Obesity, was conducted by researchers from the Universit- de Montr-al, the Institut Armand-Frappier and the Universit- de Moncton who tested the effects of biotransformed juices compared to regular blueberry drinks on mice.

2 Sep 2009

Polymyositis and dermatomyositis affected patients more prone to cardiovascular diseases

Patients suffering from two serious autoimmune disorders which cause muscular inflammation are at increased risk of developing cardiovascular disease, says a group of Montreal researchers. Dr. Christian A. Pineau and his team at the Research Institute of the McGill University Health Centre (RI-MUHC) have linked muscular inflammation to increased cardiovascular risk for the first time.

2 Sep 2009

Retail clinics offer better quality care at lower costs than other venues

A new study by Rand Corporation, published in the Annals of Internal Medicine, concludes retail clinics provide quality care at lower costs and equal or better quality than other urgent care options.

1 Sep 2009

Black hypertension patients experience poor communication with doctors than white patients

Black patients with high blood pressure experience poorer communication with their doctors than white patients do, a study led by a University of North Carolina at Chapel Hill researcher has found.

1 Sep 2009

Two human biomarker assays that play a key role in the early detection of kidney damage provide assistance in drug development

Geneuity Clinical Research Services announces the recent validation and use in clinical trials of two human biomarker assays that play a key role in the early detection of kidney damage.

29 Aug 2009

NYP/Weill Cornell research reveals that prolonged QRS duration indicates abnormal pumping of the heart

QRS duration (QRSd) is one of several measures of heart function recorded during a routine electrocardiogram (ECG). It is a composite of waves showing the length of time it takes for an electrical signal to get all the way through the pumping chambers of the heart. Prolonged QRSd is a sign of an abnormal electrical system of the heart and is often found when the heart isn't pumping efficiently.

28 Aug 2009

Omron Healthcare achieves sale milestone: 100 million blood pressure monitors sold

Omron Healthcare Co., Ltd. announced on August 28 a new sales milestone for blood pressure monitors: 100 million units sold worldwide. The first Omron digital blood pressure monitor was launched in 1973 and since then, Omron Healthcare has introduced more than 100 models used in more than 100 countries around the world.

28 Aug 2009

New study reveals that persistent job insecurity could pose a major threat to worker health

Persistent job insecurity poses a major threat to worker health, according to a new study published in the September issue of the peer-reviewed journal Social Science and Medicine.

28 Aug 2009

Angiotensin arrests lung tumor growth by inhibiting blood vessel formation

In new animal research done by investigators at Wake Forest University School of Medicine, scientists have discovered a treatment effective in mice at blocking the growth and shrinking the size of lung cancer tumors, one of the leading causes of cancer death in the world.

27 Aug 2009

Modest decline for hypertension drug industry over the next decade

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that despite generic erosion of many branded agents -- most notably Novartis's Diovan -- the hypertension drug market will experience only modest decline over the next decade.

26 Aug 2009

Research study concludes the difference in mortality between men and women depending on the type of ACS

A new study from NYU School of Medicine found that women may have a slightly higher risk of death than men in the thirty days following an acute coronary syndrome (ACS), but that these differences appear to be attributable to factors such as severity and type of ACS.

26 Aug 2009

Task Force guidelines to improve identification and treatment of high BP among young people

Comprehensive guidelines for the treatment and management of hypertension in children and adolescents are being published for the first time in the latest issue of the Journal of Hypertension.

26 Aug 2009

Hypertension (High Blood Pressure) News and Research

Further Reading

New target for cancer cure identified

The Kyoto Heart study shows positive effect of valsartan on cardiovascular outcome

LifeVantage granted third patent for Protandim

Study reveals that valsartan prevents cardiovascular events in high-risk hypertensive Japanese patients

Actelion launches new 20 mcg/mL Ventavis formulation

Irbesartan drug minimizes heart failure complications in patients with atrial fibrillation

White paper stresses the need for healthy living and prevention to be included in healthcare reform

Scientists shed light on the relationship between hypertension and obesity

Biotransformed blueberry juice can function as anti-obesity and anti-diabetic agent

Polymyositis and dermatomyositis affected patients more prone to cardiovascular diseases

Retail clinics offer better quality care at lower costs than other venues

Black hypertension patients experience poor communication with doctors than white patients

Two human biomarker assays that play a key role in the early detection of kidney damage provide assistance in drug development

NYP/Weill Cornell research reveals that prolonged QRS duration indicates abnormal pumping of the heart

Omron Healthcare achieves sale milestone: 100 million blood pressure monitors sold

New study reveals that persistent job insecurity could pose a major threat to worker health

Angiotensin arrests lung tumor growth by inhibiting blood vessel formation

Modest decline for hypertension drug industry over the next decade

Research study concludes the difference in mortality between men and women depending on the type of ACS

Task Force guidelines to improve identification and treatment of high BP among young people

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News